Invesaro

Stocks Industrials NGVT

NYSE · Industrials

Ingevity Corp (NGVT)

Ingevity Corp brought in $1.1B of revenue over the twelve months to September 30, 2026, up 8.0% from a year earlier. Net income was $59.8M, a net margin of 5.3%. Operating cash flow minus capital spending left $273.5M of free cash flow in fiscal 2025. At September 30, 2026 it held $85.4M in cash against $156.4M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.

Free, no password. An email when NGVT files with the SEC.

Price
$62.40
+3.79% on the day · November 9, 2026
52-week range $46.38 to $79.29
Market cap
$2.1B
Revenue (last 12 months)
$1.1B
+8.0% year on year
Net margin
5.3%

Key facts about Ingevity Corp

Net worth
Ingevity Corp has a market value (market cap) of $2.1B at the latest share price, and shareholders' equity of $63M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $1.2B (-2.7% year on year), with a net loss of $167.1M. Over the 12 months to September 30, 2026: revenue $1.1B, net income $59.8M.
Cash flow
In fiscal 2025 operations brought in $331.2M of cash; after $57.7M of capital spending, free cash flow was $273.5M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Ingevity Corp's next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What Ingevity Corp does

Ingevity Corp is registered with the SEC under industry code SIC 2800 (Chemicals & Allied Products). Its shares trade on NYSE under the ticker NGVT.

Revenue and profit by year

Revenue
FY18: $1.1B $1.1B FY18FY19: $1.3B $1.3B FY19FY20: $1.2B $1.2B FY20FY21: $1.4B $1.4B FY21FY22: $1.7B $1.7B FY22FY23: $1.2B $1.2B FY23FY24: $1.2B $1.2B FY24FY25: $1.2B $1.2B FY25
Net income
FY18: $169.1M $169.1M FY18FY19: $183.7M $183.7M FY19FY20: $181.4M $181.4M FY20FY21: $118.1M $118.1M FY21FY22: $211.6M $211.6M FY22FY23: -$5.4M -$5.4M FY23FY24: -$430.3M -$430.3M FY24FY25: -$167.1M -$167.1M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$1.2B$418.7M-$167.1M-$4.61$273.5M
2024$1.2B$425.9M-$430.3M-$11.85$51M
2023$1.2B$423.2M-$5.4M-$0.15$95.3M
2022$1.7B$452.6M$211.6M$5.50$170.9M
2021$1.4B$422.2M$118.1M$2.95$189.5M
2020$1.2B$397.9M$181.4M$4.37$270.3M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around February 24, 2027.

Estimated from its filing rhythm: 52 weeks after its report of February 25, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where NGVT ranks in Industrials

Revenue$1.2B
#270 of 603 in Industrials · Top 45%
Revenue growth-2.7%
#384 of 520 in Industrials · Bottom 26%
Net margin-14.3%
#431 of 523 in Industrials · Bottom 18%
Free cash flow margin23.4%
#20 of 489 in Industrials · Top 4%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Industrials

Latest SEC filings

What Ingevity Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 5, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue fell 8.4% to $305.1M versus the same quarter last year; diluted EPS $1.41 versus $1.18.
  2. November 4, 2026
  3. July 30, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 5.2% to $314.1M versus the same quarter last year; diluted EPS $1.00 versus -$4.02.
  4. July 29, 2026
  5. June 24, 2026
  6. May 15, 2026
  7. May 7, 2026
  8. May 7, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 4.1% to $258M versus the same quarter last year; diluted EPS $1.66 versus $0.56.
  9. May 6, 2026
  10. May 4, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 2, 2026. Insider transactions on SEC

What is NGVT worth? A DCF from its reported cash flow

Insider trades

What the people running Ingevity Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $1.1M worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.

Bought (open market)
$0
last 90 days
Sold
$1.1M
last 90 days
Net sold
15,092
$1.1M
DateInsiderWhatSharesPriceValueFiling
October 1, 2026 Willis J KevinDirector Received as pay 405 $71.09 $28.8K Form 4
October 1, 2026 Segal Francis DavidDirector Received as pay 335 $71.09 $23.8K Form 4
August 18, 2026 Li David HPresident & CEO, Director Soldpre-planned (10b5-1) 92 $74.71 $6.9K Form 4
August 17, 2026 Li David HPresident & CEO, Director Soldpre-planned (10b5-1) 5,000 $75.83 $379.2K Form 4
August 14, 2026 Li David HPresident & CEO, Director Soldpre-planned (10b5-1) 5,000 $75.73 $378.7K Form 4
August 13, 2026 Li David HPresident & CEO, Director Soldpre-planned (10b5-1) 5,000 $75.73 $378.7K Form 4
August 12, 2026 Li David HPresident & CEO, Director Soldpre-planned (10b5-1) 5,000 $76.62 $383.1K Form 4
August 10, 2026 Platt Phillip JohnSVP, Chief Financial Officer Shares withheld for tax 1,698 $77.04 $130.8K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns NGVT

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Vanguard Portfolio Management13G, passive 6.27% 2,209,879 April 29, 2026
Vanguard Capital Management13G, passive 5.26% 1,853,415 April 30, 2026

Latest filings below 5%: Wellington Management Group LLP 4.2% (May 15, 2026); The Vanguard Group 0% (March 27, 2026); Victory Capital Management, Inc. 2.15% (October 24, 2025); Inclusive Capital Partners, L.P. 3.2% (February 28, 2024).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 315 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.5,364,204$400.5M+66,489
Vanguard Portfolio Management LLC2,376,803$177.5M+200,072
Vanguard Capital Management LLC1,571,127$117.3M-10,744
State Street Corp1,497,321$111.8M+38,086
American Century Companies Inc1,270,958$94.9M-161,608
Wellington Management Group Llp1,075,514$80.3M-418,778
Segall Bryant & Hamill, LLC1,054,605$78.7M-54,443
Millennium Management LLC992,049$74.1M-163,323
Brown Advisory Inc974,107$72.7M-17,909
Royce & Associates LP940,417$70.2M+56,890
Geode Capital Management, LLC919,109$68.6M+31,998
Simcoe Capital Management, LLC894,072$66.8M-87,943
Dimensional Fund Advisors LP787,776$58.8M-10,933
Principal Financial Group Inc761,985$56.9M+83,948
Harvey Partners, LLC734,307$54.8M-9,193
Victory Capital Management Inc680,912$50.8M-60,252
Goldman Sachs Group Inc632,506$47.2M+58,129
Maple Rock Capital Partners Inc.603,303$45M0
Charles Schwab Investment Management Inc541,400$40.4M-66,852
Vision One Management Partners, LP535,082$40M+16,981

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

18 insiders reported holding 387,079 shares in total, about $24.2M at the last price.

HolderSharesAs of
Li David HPresident & CEO, Director 120,544 August 18, 2026
Fernandez-Moreno Luis MDirector 37,882 April 30, 2026
Hall Mary DeanEVP, Chief Financial Officer 37,427 March 2, 2026
Lynch Frederick JDirector 28,263 April 30, 2026
Platt Phillip JohnSVP, Chief Financial Officer 26,641 August 10, 2026
White Richard Allen JRSVP and Pres, Perf Chemicals 20,080 March 2, 2026
Narwold Karen GDirector 18,900 April 30, 2026
Fisher Ryan C.SVP, Gen. Counsel & Secretary 15,722 August 3, 2026
Gulyas Diane H.Director 14,788 April 30, 2026
Wright Benjamin G.Director 11,948 April 30, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about NGVT

What does Ingevity Corp do?

Ingevity Corp is a company in the Industrials sector, listed on NYSE as NGVT. Its shares trade on NYSE under the ticker NGVT.

What is Ingevity Corp's net worth?

Ingevity Corp has a market value (market cap) of $2.1B at the latest share price, and shareholders' equity of $63M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Ingevity Corp profitable?

Yes. Over the twelve months to September 30, 2026 it reported net income of $59.8M on revenue of $1.1B, a net margin of 5.3%.

How much revenue does Ingevity Corp make?

Over the twelve months to September 30, 2026 Ingevity Corp reported revenue of $1.1B. That is 8.0% more than a year earlier.

When did Ingevity Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.

When is Ingevity Corp's next earnings report?

Ingevity Corp's next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare NGVT with

Compare NGVT with any company

Follow NGVT

Get an email when Ingevity Corp files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when NGVT files with the SEC.

Where the numbers come from

Financial figures are the values Ingevity Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.